Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Medical comorbidities of patients with burning mouth syndrome.

Suga T, Takenoshita M, Toyofuku A.

Oral Dis. 2019 Aug 29. doi: 10.1111/odi.13186. [Epub ahead of print] No abstract available.

PMID:
31466124
2.

Comorbid depressive disorders and left-side dominant occlusal discomfort in patients with phantom bite syndrome.

Shinohara Y, Umezaki Y, Minami I, Watanabe M, Miura A, Mikutsuki L, Kawasaki K, Sugawara S, Trang TTH, Suga T, Watanabe T, Yoshikawa T, Takenoshita M, Motomura H, Toyofuku A.

J Oral Rehabil. 2019 Aug 9. doi: 10.1111/joor.12872. [Epub ahead of print]

PMID:
31398263
3.

Oral dysesthesia associated with autistic traits: a retrospective chart review.

Uezato A, Toyofuku A, Umezaki Y, Nishikawa T.

Eur J Oral Sci. 2019 Aug;127(4):347-350. doi: 10.1111/eos.12620. Epub 2019 May 9.

PMID:
31071244
4.

Multicenter open-label randomized phase II study of second-line panitumumab and irinotecan with or without fluoropyrimidines in patients with KRAS wild-type metastatic colorectal cancer (PACIFIC study).

Nagata N, Maeda H, Ishibashi K, Hirata K, Makiyama A, Iwamoto S, Takemoto H, Imasato M, Yoshida Y, Munemoto Y, Tanaka C, Morita Y, Hotta Y, Toyofuku A, Nagasaka T, Morita S, Sakamoto J, Mishima H.

Med Oncol. 2019 Apr 24;36(6):46. doi: 10.1007/s12032-019-1254-4.

PMID:
31020480
5.

Pharmacotherapeutic outcomes in atypical odontalgia: determinants of pain relief.

Tu TTH, Miura A, Shinohara Y, Mikuzuki L, Kawasaki K, Sugawara S, Suga T, Watanabe T, Aota Y, Umezaki Y, Takenoshita M, Toyofuku A.

J Pain Res. 2019 Feb 27;12:831-839. doi: 10.2147/JPR.S188362. eCollection 2019.

6.

Change of Cerebral Blood Flow After a Successful Pharmacological Treatment of Phantom Bite Syndrome: A Case Report.

Umezaki Y, Tu TTH, Toriihara A, Sato Y, Naito T, Toyofuku A.

Clin Neuropharmacol. 2019 Mar/Apr;42(2):49-51. doi: 10.1097/WNF.0000000000000328.

7.

Current management strategies for the pain of elderly patients with burning mouth syndrome: a critical review.

Tu TTH, Takenoshita M, Matsuoka H, Watanabe T, Suga T, Aota Y, Abiko Y, Toyofuku A.

Biopsychosoc Med. 2019 Jan 31;13:1. doi: 10.1186/s13030-019-0142-7. eCollection 2019. Review.

8.

Burning mouth syndrome: The challenge of an aging population.

Suga T, Watanabe T, Aota Y, Nagamine T, Toyofuku A.

Geriatr Gerontol Int. 2018 Dec;18(12):1649-1650. doi: 10.1111/ggi.13548. No abstract available.

PMID:
30548780
9.

Clinical characteristics and course of oral somatic delusions: a retrospective chart review of 606 cases in 5 years.

Umezaki Y, Miura A, Shinohara Y, Mikuzuki L, Sugawara S, Kawasaki K, Tu TT, Watanabe T, Suga T, Watanabe M, Takenoshita M, Yoshikawa T, Uezato A, Nishikawa T, Hoshiko K, Naito T, Motomura H, Toyofuku A.

Neuropsychiatr Dis Treat. 2018 Aug 13;14:2057-2065. doi: 10.2147/NDT.S167527. eCollection 2018.

10.

Psychology: Psychiatric dimension to oral pain.

Tu TTH, Uezato A, Toyofuku A.

Br Dent J. 2018 Aug 24;225(4):276. doi: 10.1038/sj.bdj.2018.701. No abstract available.

PMID:
30141507
11.

The clinical impact of human T-lymphotrophic virus type 1 (HTLV-1) infection on the development of adult T-cell leukemia-lymphoma (ATL) or HTLV-1-associated myelopathy (HAM) / atypical HAM after allogeneic hematopoietic stem cell transplantation (allo-HSCT) and renal transplantation.

Kawano N, Yoshida S, Kawano S, Kuriyama T, Tahara Y, Toyofuku A, Manabe T, Doi A, Terasaka S, Yamashita K, Ueda Y, Ochiai H, Marutsuka K, Yamano Y, Shimoda K, Kikuchi I.

J Clin Exp Hematop. 2018 Sep 19;58(3):107-121. doi: 10.3960/jslrt.18011. Epub 2018 Aug 8.

12.

An increase in salivary flow with amitriptyline may indicate treatment resistance in burning mouth syndrome.

Kawasaki K, Nagamine T, Watanabe T, Suga T, Tu TTH, Sugawara S, Mikuzuki L, Miura A, Shinohara Y, Yoshikawa T, Takenoshita M, Toyofuku A.

Asia Pac Psychiatry. 2018 Sep;10(3):e12315. doi: 10.1111/appy.12315. Epub 2018 Mar 25. No abstract available.

PMID:
29575764
13.

Psychiatric comorbidities in patients with Atypical Odontalgia.

Miura A, Tu TTH, Shinohara Y, Mikuzuki L, Kawasaki K, Sugawara S, Suga T, Watanabe T, Watanabe M, Umezaki Y, Yoshikawa T, Motomura H, Takenoshita M, Maeda H, Toyofuku A.

J Psychosom Res. 2018 Jan;104:35-40. doi: 10.1016/j.jpsychores.2017.11.001. Epub 2017 Nov 7.

14.

Interaction between calcitonin gene-related peptide-immunoreactive neurons and satellite cells via P2Y12 R in the trigeminal ganglion is involved in neuropathic tongue pain in rats.

Sugawara S, Okada S, Katagiri A, Saito H, Suzuki T, Komiya H, Kanno K, Ohara K, Iinuma T, Toyofuku A, Iwata K.

Eur J Oral Sci. 2017 Dec;125(6):444-452. doi: 10.1111/eos.12382. Epub 2017 Oct 11.

PMID:
29023985
15.

Evaluating Burning Mouth Syndrome as a Comorbidity of Atypical Odontalgia: The Impact on Pain Experiences.

Tu TTH, Miura A, Shinohara Y, Mikuzuki L, Kawasaki K, Sugawara S, Suga T, Watanabe T, Watanabe M, Umezaki Y, Yoshikawa T, Motomura H, Takenoshita M, Toyofuku A.

Pain Pract. 2018 Jun;18(5):580-586. doi: 10.1111/papr.12647. Epub 2017 Nov 20.

PMID:
28972293
16.

Phenotypic change in trigeminal ganglion neurons associated with satellite cell activation via extracellular signal-regulated kinase phosphorylation is involved in lingual neuropathic pain.

Mikuzuki L, Saito H, Katagiri A, Okada S, Sugawara S, Kubo A, Ohara K, Lee J, Toyofuku A, Iwata K.

Eur J Neurosci. 2017 Sep;46(6):2190-2202. doi: 10.1111/ejn.13667. Epub 2017 Sep 4.

PMID:
28834578
17.

Clinical features of atypical odontalgia; three cases and literature reviews.

Takenoshita M, Miura A, Shinohara Y, Mikuzuki R, Sugawara S, Tu TTH, Kawasaki K, Kyuragi T, Umezaki Y, Toyofuku A.

Biopsychosoc Med. 2017 Aug 3;11:21. doi: 10.1186/s13030-017-0106-8. eCollection 2017.

18.

Cognitive behavioral therapy for psychosomatic problems in dental settings.

Matsuoka H, Chiba I, Sakano Y, Toyofuku A, Abiko Y.

Biopsychosoc Med. 2017 Jun 13;11:18. doi: 10.1186/s13030-017-0102-z. eCollection 2017. Review.

19.

Two Cases of Oral Somatic Delusions Ameliorated With Brain Perfusion Asymmetry: A Case Report.

Umezaki Y, Uezato A, Toriihara A, Nishikawa T, Toyofuku A.

Clin Neuropharmacol. 2017 Mar/Apr;40(2):97-99. doi: 10.1097/WNF.0000000000000207.

20.

Low-Dose Aripiprazole Augmentation in Amitriptyline-Resistant Burning Mouth Syndrome: Results from Two Cases.

Takenoshita M, Motomura H, Toyofuku A.

Pain Med. 2017 Apr 1;18(4):814-815. doi: 10.1093/pm/pnw200. No abstract available.

21.

Oral cenesthopathy.

Umezaki Y, Miura A, Watanabe M, Takenoshita M, Uezato A, Toriihara A, Nishikawa T, Toyofuku A.

Biopsychosoc Med. 2016 Jun 10;10:20. doi: 10.1186/s13030-016-0071-7. eCollection 2016. Review.

22.

Low-dose aripiprazole for refractory burning mouth syndrome.

Umezaki Y, Takenoshita M, Toyofuku A.

Neuropsychiatr Dis Treat. 2016 May 19;12:1229-31. doi: 10.2147/NDT.S94426. eCollection 2016.

23.

Psychosomatic problems in dentistry.

Toyofuku A.

Biopsychosoc Med. 2016 Apr 30;10:14. doi: 10.1186/s13030-016-0068-2. eCollection 2016. Review.

24.

Clinical Features and Treatment Outcomes of 81 Patients with Aggressive Type Adult T-cell Leukemia-lymphoma at a Single Institution over a 7-year Period (2006-2012).

Kawano N, Yoshida S, Kuriyama T, Tahara Y, Yamashita K, Nagahiro Y, Kawano J, Koketsu H, Toyofuku A, Manabe T, Beppu K, Ono N, Himeji D, Yokota-Ikeda N, Inoue S, Ochiai H, Sonoda KH, Shimoda K, Ishikawa F, Ueda A.

Intern Med. 2015;54(12):1489-98. doi: 10.2169/internalmedicine.54.1953. Epub 2015 Jun 15.

25.

Comparison of cerebral blood flow in oral somatic delusion in patients with and without a history of depression: a comparative case series.

Watanabe M, Umezaki Y, Miura A, Shinohara Y, Yoshikawa T, Sakuma T, Shitano C, Katagiri A, Takenoshita M, Toriihara A, Uezato A, Nishikawa T, Motomura H, Toyofuku A.

BMC Psychiatry. 2015 Mar 10;15:42. doi: 10.1186/s12888-015-0422-0.

26.

Oral Dysesthesia Rating Scale: a tool for assessing psychosomatic symptoms in oral regions.

Uezato A, Toyofuku A, Umezaki Y, Watanabe M, Toriihara A, Tomita M, Yamamoto N, Kurumaji A, Nishikawa T.

BMC Psychiatry. 2014 Dec 21;14:1696. doi: 10.1186/s12888-014-0359-8.

27.

Psychiatric comorbidities and psychopharmacological outcomes of phantom bite syndrome.

Watanabe M, Umezaki Y, Suzuki S, Miura A, Shinohara Y, Yoshikawa T, Sakuma T, Shitano C, Katagiri A, Sato Y, Takenoshita M, Toyofuku A.

J Psychosom Res. 2015 Mar;78(3):255-9. doi: 10.1016/j.jpsychores.2014.11.010. Epub 2014 Nov 15.

28.

Brain perfusion asymmetry in patients with oral somatic delusions.

Umezaki Y, Katagiri A, Watanabe M, Takenoshita M, Sakuma T, Sako E, Sato Y, Toriihara A, Uezato A, Shibuya H, Nishikawa T, Motomura H, Toyofuku A.

Eur Arch Psychiatry Clin Neurosci. 2013 Jun;263(4):315-23. doi: 10.1007/s00406-013-0390-7. Epub 2013 Jan 29.

29.

Current evidence on atypical odontalgia: diagnosis and clinical management.

Abiko Y, Matsuoka H, Chiba I, Toyofuku A.

Int J Dent. 2012;2012:518548. doi: 10.1155/2012/518548. Epub 2012 Jul 9.

30.

Satellite glial cell P2Y12 receptor in the trigeminal ganglion is involved in lingual neuropathic pain mechanisms in rats.

Katagiri A, Shinoda M, Honda K, Toyofuku A, Sessle BJ, Iwata K.

Mol Pain. 2012 Mar 30;8:23. doi: 10.1186/1744-8069-8-23.

31.

[Psychopharmacology and oral psychosomatic disorder].

Yoshikawa T, Toyofuku A.

Nihon Rinsho. 2012 Jan;70(1):122-5. Review. Japanese.

PMID:
22413505
32.

Improvement of asymmetrical temporal blood flow in refractory oral somatic delusion after successful electroconvulsive therapy.

Uezato A, Yamamoto N, Kurumaji A, Toriihara A, Umezaki Y, Toyofuku A, Nishikawa T.

J ECT. 2012 Mar;28(1):50-1. doi: 10.1097/YCT.0b013e31822e581e.

PMID:
21983760
33.

Milnacipran dose-effect study in patients with burning mouth syndrome.

Kato Y, Sato T, Katagiri A, Umezaki Y, Takenoshita M, Yoshikawa T, Sato Y, Toyofuku A.

Clin Neuropharmacol. 2011 Jul-Aug;34(4):166-9. doi: 10.1097/WNF.0b013e318227f100.

PMID:
21738023
34.

Psychiatric diagnoses in patients with burning mouth syndrome and atypical odontalgia referred from psychiatric to dental facilities.

Takenoshita M, Sato T, Kato Y, Katagiri A, Yoshikawa T, Sato Y, Matsushima E, Sasaki Y, Toyofuku A.

Neuropsychiatr Dis Treat. 2010 Oct 13;6:699-705. doi: 10.2147/NDT.S12605.

35.

Standardized uptake values for breast carcinomas assessed by fluorodeoxyglucose-positron emission tomography correlate with prognostic factors.

Ikenaga N, Otomo N, Toyofuku A, Ueda Y, Toyoda K, Hayashi T, Nishikawa K, Tanaka M.

Am Surg. 2007 Nov;73(11):1151-7.

PMID:
18092653
36.

[From psychosomatic dentistry to brain dentistry].

Toyofuku A.

Kokubyo Gakkai Zasshi. 2007 Oct;74(3):161-8. Review. Japanese. No abstract available.

PMID:
18027579
37.

Treatment of phantom bite syndrome with milnacipran - a case series.

Toyofuku A, Kikuta T.

Neuropsychiatr Dis Treat. 2006 Sep;2(3):387-90.

38.

Natural killer T-cells participate in rejection of islet allografts in the liver of mice.

Toyofuku A, Yasunami Y, Nabeyama K, Nakano M, Satoh M, Matsuoka N, Ono J, Nakayama T, Taniguchi M, Tanaka M, Ikeda S.

Diabetes. 2006 Jan;55(1):34-9.

39.

Cyclic and characteristic expression of phosphorylated Akt in human endometrium and decidual cells in vivo and in vitro.

Toyofuku A, Hara T, Taguchi T, Katsura Y, Ohama K, Kudo Y.

Hum Reprod. 2006 May;21(5):1122-8. Epub 2005 Dec 22.

PMID:
16373405
40.

Valpha14 NK T cell-triggered IFN-gamma production by Gr-1+CD11b+ cells mediates early graft loss of syngeneic transplanted islets.

Yasunami Y, Kojo S, Kitamura H, Toyofuku A, Satoh M, Nakano M, Nabeyama K, Nakamura Y, Matsuoka N, Ikeda S, Tanaka M, Ono J, Nagata N, Ohara O, Taniguchi M.

J Exp Med. 2005 Oct 3;202(7):913-8. Epub 2005 Sep 26.

41.

Beneficial effects of costimulatory blockade with anti-inducible costimulator antibody in conjunction with CTLA4Ig on prevention of islet xenograft rejection from rat to mouse.

Nabeyama K, Yasunami Y, Toyofuku A, Nakano M, Satoh M, Matsuoka N, Ono J, Kamada M, Uede T, Todo S, Ikeda S.

Transplantation. 2004 Dec 15;78(11):1590-6.

PMID:
15591946
42.

Induction of G1 cell cycle arrest in human umbilical vein endothelial cells by flavone's inhibition of the extracellular signal regulated kinase cascade.

Arakaki N, Toyofuku A, Emoto Y, Nagao T, Kuramoto Y, Shibata H, Higuti T.

Biochem Cell Biol. 2004 Oct;82(5):583-8.

PMID:
15499387
43.

A case of temporo-mandibular disorder with fibromyalgia treated with the antidepressant, milnacipran.

Toyofuku A, Miyako H.

Hum Psychopharmacol. 2004 Jul;19(5):357-8. No abstract available.

PMID:
15252831
44.

Mechanisms regulating the expression of indoleamine 2,3-dioxygenase during decidualization of human endometrium.

Kudo Y, Hara T, Katsuki T, Toyofuku A, Katsura Y, Takikawa O, Fujii T, Ohama K.

Hum Reprod. 2004 May;19(5):1222-30. Epub 2004 Apr 7.

PMID:
15070879
45.

Possible role of cell surface H+ -ATP synthase in the extracellular ATP synthesis and proliferation of human umbilical vein endothelial cells.

Arakaki N, Nagao T, Niki R, Toyofuku A, Tanaka H, Kuramoto Y, Emoto Y, Shibata H, Magota K, Higuti T.

Mol Cancer Res. 2003 Nov;1(13):931-9.

46.

Efficacy of milnacipran for glossodynia patients.

Toyofuku A.

Int J Psychiatry Clin Pract. 2003;7 Suppl 1:23-4. doi: 10.1080/13651500310000861.

PMID:
24937416
47.

Outcome after steroid withdrawal in adult renal transplant patients receiving tacrolimus-based immunosuppression.

Chakrabarti P, Wong HY, Toyofuku A, Scantlebury VP, Jordan ML, Vivas C, Jain AB, McCauley J, Johnston J, Randhawa PS, Hakala TR, Simmons RL, Fung JJ, Starzl TE, Shapiro R.

Transplant Proc. 2001 Feb-Mar;33(1-2):1235-6. No abstract available.

48.

[A case of so-called carcinosarcoma of the lung].

Sano T, Akao M, Mtsuo K, Ikeda S, Nishimura A, Hachiya Y, Toyofuku A, Matsumoto K, Tokunaga M, Tanimura A.

Kyobu Geka. 1996 May;49(5):412-5. Japanese.

PMID:
8992049

Supplemental Content

Loading ...
Support Center